FIELD: organic chemistry, medicine. SUBSTANCE: invention proposes the application of fumaric acid alkyl esters of the general formula (1) or (2) where n = 1, 2 in transplantation medicine used for suppression of response "transplant against the host". EFFECT: expanded assortment of agents of indicated designation. 14 cl, 2 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF FUMARIC ACID DERIVATIVES | 1998 |
|
RU2197963C2 |
FUMARIC ACID-BASE MICROTABLETS | 1999 |
|
RU2210366C2 |
DERIVATIVES OF FUMARIC ACID AS NF-kappaB INHIBITOR | 2002 |
|
RU2282440C2 |
APPLICATION OF FUMARIC ACID DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | 2000 |
|
RU2218918C1 |
USING FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC FAILURE, MYOCARDIAL INFARCTION AND ANGINA | 2007 |
|
RU2459621C2 |
USING DERIVATIVES OF FUMARIC ACID IN TREATMENT OF CARDIAC INSUFFICIENCY AND ASTHMA | 2004 |
|
RU2313339C2 |
APPLICATION OF ACID ALKYLFUMARATES FOR TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS, NEURODERMITIS AND CHRONIC CICATRIZING ENTERITIS (CROHN'S DISEASE) | 1998 |
|
RU2197233C2 |
FUMARIC ACID AMIDES | 2002 |
|
RU2290946C2 |
DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
PHARMACEUTICAL COMPOSITIONS BASED ON MYCOPHENOLIC ACID SALT WITH ENTEROSOLUBLE COATING | 1997 |
|
RU2203659C2 |
Authors
Dates
2003-08-20—Published
1999-08-20—Filed